140 related articles for article (PubMed ID: 36283631)
1. Improving physicochemical properties and pharmacological activities of ternary co-amorphous systems.
Fang X; Hu Y; Yang G; Shi W; Lu S; Cao Y
Eur J Pharm Biopharm; 2022 Dec; 181():22-35. PubMed ID: 36283631
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Formation Mechanism of Coamorphous Andrographolide-Oxymatrine Based on Molecular Dynamics and Spectroscopy.
Fang X; Hu Y; Huang Z; Han L; Li B; Lu S; Cao Y
J Pharm Sci; 2022 Jul; 111(7):2056-2071. PubMed ID: 35167885
[TBL] [Abstract][Full Text] [Related]
3. Ball milling and hot-melt extrusion of indomethacin-l-arginine-vinylpyrrolidone-vinyl acetate copolymer: Solid-state properties and dissolution performance.
Iemtsev A; Zemánková A; Hassouna F; Mathers A; Klajmon M; Slámová M; Malinová L; Fulem M
Int J Pharm; 2022 Feb; 613():121424. PubMed ID: 34968683
[TBL] [Abstract][Full Text] [Related]
4. Effects of polymer addition on the non-strongly interacting binary co-amorphous system carvedilol-tryptophan.
Wang Y; Grohganz H; Rades T
Int J Pharm; 2022 Apr; 617():121625. PubMed ID: 35259442
[TBL] [Abstract][Full Text] [Related]
5. Apigenin-oxymatrine binary co-amorphous mixture: Enhanced solubility, bioavailability, and anti-inflammatory effect.
Li B; Hu Y; Wu T; Feng Y; Jiang C; Du H; Lu S
Food Chem; 2022 Mar; 373(Pt B):131485. PubMed ID: 34740050
[TBL] [Abstract][Full Text] [Related]
6. Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability.
Liu X; Shen L; Zhou L; Wu W; Liang G; Zhao Y; Wu W
Eur J Pharm Biopharm; 2024 Jul; 200():114333. PubMed ID: 38768766
[TBL] [Abstract][Full Text] [Related]
7. Tannic acid as a co-former in co-amorphous systems: Enhancing their physical stability, solubility and dissolution behavior.
Fael H; Demirel AL
Int J Pharm; 2020 May; 581():119284. PubMed ID: 32243965
[TBL] [Abstract][Full Text] [Related]
8. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
9. Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors.
An JH; Lim C; Kiyonga AN; Chung IH; Lee IK; Mo K; Park M; Youn W; Choi WR; Suh YG; Jung K
Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30189645
[TBL] [Abstract][Full Text] [Related]
10. Improving co-amorphous drug formulations by the addition of the highly water soluble amino Acid, proline.
Jensen KT; Löbmann K; Rades T; Grohganz H
Pharmaceutics; 2014 Jul; 6(3):416-35. PubMed ID: 25025400
[TBL] [Abstract][Full Text] [Related]
11. Dissolution changes in drug-amino acid/biotin co-amorphous systems: Decreased/increased dissolution during storage without recrystallization.
Zou Z; Huang Q; Li X; Liu X; Yin L; Zhao Y; Liang G; Wu W
Eur J Pharm Sci; 2023 Sep; 188():106526. PubMed ID: 37442486
[TBL] [Abstract][Full Text] [Related]
12. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
13. Development and Characterization of Microstructured, Spray-Dried Co-Amorphous Mixture of Antidiabetic Agents Stabilized by Silicate.
Wairkar S; Gaud R
AAPS PharmSciTech; 2019 Mar; 20(3):141. PubMed ID: 30868308
[TBL] [Abstract][Full Text] [Related]
14. Application of a Salt Coformer in a Co-Amorphous Drug System Dramatically Enhances the Glass Transition Temperature: A Case Study of the Ternary System Carbamazepine, Citric Acid, and l-Arginine.
Ueda H; Wu W; Löbmann K; Grohganz H; Müllertz A; Rades T
Mol Pharm; 2018 May; 15(5):2036-2044. PubMed ID: 29630842
[TBL] [Abstract][Full Text] [Related]
15. Sinapic Acid Co-Amorphous Systems with Amino Acids for Improved Solubility and Antioxidant Activity.
Garbiec E; Rosiak N; Tykarska E; Zalewski P; Cielecka-Piontek J
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982605
[TBL] [Abstract][Full Text] [Related]
16. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the physicochemical properties of Co-amorphous naproxen-indomethacin by naproxen-sodium.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Int J Pharm; 2017 Jun; 526(1-2):88-94. PubMed ID: 28392278
[TBL] [Abstract][Full Text] [Related]
18. Coamorphous System of Florfenicol-Oxymatrine for Improving the Solubility and Dissolution Rate of Florfenicol: Preparation, Characterization and Molecular Dynamics Simulation.
Li B; Hu Y; Guo Y; Xu R; Fang X; Xiao X; Jiang C; Lu S
J Pharm Sci; 2021 Jun; 110(6):2544-2554. PubMed ID: 33577826
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
20. Comparison of co-former performance in co-amorphous formulations: Single amino acids, amino acid physical mixtures, amino acid salts and dipeptides as co-formers.
Wu W; Grohganz H; Rades T; Löbmann K
Eur J Pharm Sci; 2021 Jan; 156():105582. PubMed ID: 33039568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
